Intravitreal ranibizumab versus laser photocoagulation for retinopathy of prematurity: efficacy, anatomical outcomes and safety.
Hyun Goo KangEun Young ChoiSuk Ho ByeonSung Soo KimHyoung Jun KohSung Chul LeeMin KimPublished in: The British journal of ophthalmology (2018)
Intravitreal ranibizumab for ROP appears to achieve similar therapeutic effects than did laser photocoagulation, but with fewer surgical complications such as retinal detachment or macular dragging.